BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16957342)

  • 1. Protein misfolding disorders and rational design of antimisfolding agents.
    Estrada LD; Yowtak J; Soto C
    Methods Mol Biol; 2006; 340():277-93. PubMed ID: 16957342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic strategies for the treatment of protein-misfolding diseases.
    Rochet JC
    Expert Rev Mol Med; 2007 Jun; 9(17):1-34. PubMed ID: 17597554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein misfolding and aggregation by small rationally-designed peptides.
    Estrada LD; Soto C
    Curr Pharm Des; 2006; 12(20):2557-67. PubMed ID: 16842178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide model systems for amyloid fiber formation: design strategies and validation methods.
    Esteras-Chopo A; Pastor MT; López de la Paz M
    Methods Mol Biol; 2006; 340():253-76. PubMed ID: 16957341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switch-peptides: design and characterization of controllable super-amyloid-forming host-guest peptides as tools for identifying anti-amyloid agents.
    Camus MS; Dos Santos S; Chandravarkar A; Mandal B; Schmid AW; Tuchscherer G; Mutter M; Lashuel HA
    Chembiochem; 2008 Sep; 9(13):2104-12. PubMed ID: 18683159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch-peptides as folding precursors in self-assembling peptides and amyloid fibrillogenesis.
    Tuchscherer G; Chandravarkar A; Camus MS; Bérard J; Murat K; Schmid A; Mimna R; Lashuel HA; Mutter M
    Biopolymers; 2007; 88(2):239-52. PubMed ID: 17206626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo design of monomeric beta-hairpin and beta-sheet peptides.
    Pantoja-Uceda D; Santiveri CM; Jiménez MA
    Methods Mol Biol; 2006; 340():27-51. PubMed ID: 16957331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of transthyretin amyloid disease by changing protein misfolding energetics.
    Hammarström P; Wiseman RL; Powers ET; Kelly JW
    Science; 2003 Jan; 299(5607):713-6. PubMed ID: 12560553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid peptides and proteins in review.
    Harrison RS; Sharpe PC; Singh Y; Fairlie DP
    Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
    Kapurniotu A; Schmauder A; Tenidis K
    J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategy for the generation of specific D-peptide amyloid inhibitors.
    Esteras-Chopo A; Pastor MT; Serrano L; López de la Paz M
    J Mol Biol; 2008 Apr; 377(5):1372-81. PubMed ID: 18328503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of protein misfolding in the pathogenesis of human diseases.
    Ellisdon AM; Bottomley SP
    IUBMB Life; 2004 Mar; 56(3):119-23. PubMed ID: 15185744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of polyQ-mediated aggregation is dramatically affected by the number and location of surrounding domains.
    Robertson AL; Bate MA; Buckle AM; Bottomley SP
    J Mol Biol; 2011 Nov; 413(4):879-87. PubMed ID: 21945530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the mysteries of protein folding and misfolding.
    Ecroyd H; Carver JA
    IUBMB Life; 2008 Dec; 60(12):769-74. PubMed ID: 18767168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
    Esteras-Chopo A; Morra G; Moroni E; Serrano L; Lopez de la Paz M; Colombo G
    J Mol Biol; 2008 Oct; 383(1):266-80. PubMed ID: 18703072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-protein amino acids in the design of secondary structure scaffolds.
    Mahalakshmi R; Balaram P
    Methods Mol Biol; 2006; 340():71-94. PubMed ID: 16957333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-induced folding and fibril formation of coiled-coil-based model peptides.
    Wagner SC; Roskamp M; Pallerla M; Araghi RR; Schlecht S; Koksch B
    Small; 2010 Jun; 6(12):1321-8. PubMed ID: 20517875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.